Marco Exams enriches laboratory reports with evidence-based clinical interpretation, differentiating the lab by the quality and depth of its reports. It processes genetic, pathological, and molecular results and adds diagnostic, prognostic, and therapeutic context to each report.
Some answers to questions we often receive
Marco Exams connects to the lab's LIMS via API. When the technical result is ready, Marco automatically generates the clinical interpretation layer with no additional manual intervention.
Yes. Marco Exams allows configuring the report template with the laboratory's brand, included fields, and level of clinical detail according to each client's needs.
Marco Exams continuously updates its knowledge base with newly clinically relevant variants, FDA/EMA-approved biomarkers, and updated reporting guidelines, with no intervention required from the laboratory team.
Marco Exams reports follow the ACMG/AMP variant classification standards and the biomarker reporting guidelines of ESMO, NCCN, and CAP.
Yes. Marco Exams is designed to process large volumes of reports concurrently, automatically scaling to the lab's demand without affecting turnaround times.
Yes. Laboratories can position Marco Exams-enriched reports as a value-added service for physicians, hospitals, and clinics, differentiating themselves from competitors through the depth of clinical interpretation.
Oncology genomics labs want to differentiate themselves by delivering reports with greater clinical value, but lack the medical resources to write personalized clinical interpretations for each patient.
